With few exceptions, the most commonly recommended triple Helicobacter pylori regimen
(proton pump inhibitor (PPI), amoxicillin and clarithromycin) now provides unacceptably low …

Even with the currently most effective treatment regimens, about 10–20% of patients will fail
to obtain eradication of Helicobacter pylori infection. Therefore, in designing a treatment …

Background: The effectiveness of Helicobacter pylori eradication regimens has not been
extensively investigated in the clinical practice setting. The optimal treatment choice after an …

Triple therapy, consisting of two antibiotics, clarithomycin and amoxicillin or metronidazole in
combination with a proton pump inhibitor (PPI) has become the first-line option for infection …

Treatment of H. pylori infection is challenged by a dramatic fall in eradication rates all over
the world. Newer regimens have been introduced including sequential, quadruple therapies …

Background: Managing Helicobacter pylori infection requires constant decision making, and
each decision is open to possible errors. Aim: The aim was to evaluate common mistakes in …

BACKGROUND: The use of Helicobacter pylori eradication therapy is advocated in an
increasing variety of situations. It is therefore important to optimise current strategies to …

Background: Ten‐day sequential therapy with a proton pump inhibitor (PPI) and amoxicillin
followed by a PPI, clarithromycin, and an imidazole typically achieves Helicobacter pylori …

Although Helicobacter pylori infection is both a common and a serious bacterial infection,
antimicrobial therapies have rarely been optimized, are prescribed empirically, and provide …

Increasing resistance to antibiotics worldwide has adverse effects on the effectiveness of
standard therapies to eradicate Helicobacter pylori infection. We reviewed guidelines …